小児IgA血管炎診療ガイドライン　2023

出版社： 診断と治療社
著者：
発行日： 2023-07-07
分野： 臨床医学：内科  >  小児科学一般
ISBN： 9784787825636
電子書籍版： 2023-07-07 （電子版）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

4,400 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

4,400 円(税込)

購入する

商品紹介

小児IgA血管炎は皮膚症状・関節症状・消化器症状を三主徴とする小児に好発する血管炎である．小児期には頻度の少なくない疾患とされるが，全身性の疾患で合併症・併存症が多岐に及ぶため，治療には専門的な知識が要されることから、これまで国内には診療ガイドラインがなかった．この度学会を横断したガイドライン作成チームが結成され，国内で初の診療ガイドラインが上梓された．

目次

  • 発刊にあたって
    はじめに
    小児IgA血管炎診療ガイドライン2023　委員一覧
    本ガイドラインの作成について
    CQ・推奨一覧


    ◎小児IgA血管炎に対する治療の概略
    ◎小児紫斑病性腎炎に対する治療の概略

    I　総論

    　1．小児IgA血管炎の概念と病態
    　2．小児IgA血管炎の疫学と予後
    　3．小児IgA血管炎の診断
    　4．小児IgA血管炎の皮膚症状
    　5．小児IgA血管炎の皮膚病理組織像
    　6．小児IgA血管炎の関節症状
    　7．小児IgA血管炎の消化器症状
    　8．小児IgA血管炎のまれな合併症
    　9．小児IgA血管炎の治療総論
    　10．小児紫斑病性腎炎の概念と病態
    　11．小児紫斑病性腎炎の診断
    　12．小児紫斑病性腎炎の臨床分類，病理分類およびそれらと予後の相関
    　13．小児紫斑病性腎炎の治療総論

    II　クリニカルクエスチョン（CQ）

    　CQ1　小児IgA血管炎患者に安静や運動制限は推奨されるか？
    　CQ2　小児IgA血管炎患者に止血薬，血管強化薬投与は推奨されるか？
    　CQ3　小児IgA血管炎患者の関節症状に消炎鎮痛薬やステロイド薬投与は推奨されるか？
    　CQ4　小児IgA血管炎患者の消化器症状にステロイド薬投与は推奨されるか？
    　CQ5　小児IgA血管炎患者の消化器症状に第XIII因子製剤投与は推奨されるか？
    　CQ6　小児IgA血管炎患者の消化器症状に抗潰瘍薬投与は推奨されるか？
    　CQ7　ステロイド薬に効果不十分な小児IgA血管炎重症／難治患者（腎炎を除く）に対する
    　　　　　追加治療には，どのようなものがあるか？
    　CQ8　小児紫斑病性腎炎の発症予防にステロイド薬は推奨されるか？　
    　CQ9　小児紫斑病性腎炎にレニン・アンジオテンシン系（RA系）阻害薬は推奨されるか？
    　CQ10 小児紫斑病性腎炎の重症例にステロイド薬および免疫抑制薬は推奨されるか？
    　CQ11 小児紫斑病性腎炎の重症例にステロイドパルス療法は推奨されるか？
    　CQ12 小児紫斑病性腎炎の重症例にパルスウロキナーゼ療法は推奨されるか？
    　CQ13 小児紫斑病性腎炎の重症例に血漿交換療法は推奨されるか？
    　CQ14 小児紫斑病性腎炎の重症例に口蓋扁桃摘出術およびステロイドパルス療法との
    　　　　　併用は推奨されるか？

    PubMed検索式および検索件数

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 総論

P.4 掲載の参考文献
1) 五十嵐徹, 高山良子 : IgA血管炎. 小児リウマチ学. 南山堂, 2021 : 189-192.
 
2) 川名誠司 : IgA血管炎. 川名誠司, 陳科榮 (編), 皮膚血管炎. 第2版, 医学書院, 2022 : 145-163.
 
3) Jennette JC, Falk RJ, Andrassy K, et al. : Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994 ; 37 : 187-192.
PubMed
4) Mills JA, Michel BA, Bloch DA, et al. : The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum 1990 ; 33 : 1114-1121.
PubMed
5) Ozen S, Ruperto N, Dillon MJ, et al. : EULAR/PReS endorsed consensus criteria for the classification childhood vasculitis, Ann Rheum Dis 2006 ; 65 : 936-941.
PubMed
6) Ozen S, Pistorio A, Iusan SM, et al. : EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis : Ankara 2008. Part II : Final classification criteria. Ann Rheum Dis 2010 ; 69 : 798-806.
PubMed
7) Jennette JC, Falk RJ, Bacon PA, et al. : 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitis. Arthritis Rheum 2013 ; 65 : 1-11.
 
8) 日本循環器学会, 他 : 血管炎症候群の診療ガイドライン (2017年改訂版). 2018 : 78-83 (https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2017_isobe_h.pdf) (参照 2022-5-20)
 
9) 日本皮膚科学血管炎・血管障害診療ガイドライン改訂版作成委員会 : 血管炎・血管障害診療ガイドライン 2016年改訂版. 日皮会誌 2017 ; 127 : 299-415.
 
10) Kawana S, Ohta M, Nishiyama S : Value of the assay for IgA-containing circulating immune complexes in Henoch-Schonlein purpura. Dermatologia 1986 ; 172 : 245-253.
 
11) Narimatsu Y, Kubota T, Furukawa S, et al. : Effect of glycosylation on cis/trans isomerization of prolines in IgA1-hinge peptide. J Am Chem Soc 2010 ; 132 : 5548-5549.
PubMed
12) Suzuki H, Yasutake J, Makita Y, et al. : IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kid Int 2018 ; 93 : 700-705.
 
13) 矢田純一 (著) : III型アレルギー. 医系免疫学改訂 16版. 中外医学社, 2021 : 813-816.
 
14) Heineke MH, Ballering AV, Jamin A, et al. : New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schonlein purpura). Autoimmun Rev 2017 ; 16 : 1246-1253.
PubMed
P.7 掲載の参考文献
1) Jelusic M, Sestan M : IgA vasculitis or Henoch-Schonlein purpura : genetics and beyond. Pediatr Nephrol 2021 ; 36 : 2149-2153.
 
2) Ozen S, Marks SD, Brogan P, et al. : European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 2019 ; 58 : 1607-1616.
PubMed
3) Oni L, Sampath S : Childhood IgA Vasculitis (Henoch Schonlein Purpura)-Advances and Knowledge Gaps. Front Pediatr 2019 ; 7 : 257.
PubMed
4) Peruzzi L, Coppo R : IgA vasculitis nephritis in children and adults : one or different entities? Pediatr Nephrol 2021 ; 36 : 2615-2625.
PubMed
5) Kawasaki Y, Suyama K, Yugeta E, et al. : The incidence and severity of Henoch-Schonlein purpura nephritis over a 22-year period in Fukushima Prefecture, Japan. Int Urol Nephrol 2010 ; 42 : 1023-1029.
 
6) Jauhola O, Ronkainen J, Koskimies O, et al. : Clinical course of extrarenal symptoms in Henoch-Schonlein purpura : a 6-month prospective study. Arch Dis Child 2010 ; 95 : 871-876.
PubMed
7) Hastings MC, Rizk DV, Kiryluk K, et al. : IgA vasculitis with nephritis : update of pathogenesis with clinical implications. Pediatr Nephrol 2022 ; 37 : 719-733.
PubMed
8) Coppo R, Andrulli S, Amore A, et al. : Predictors of outcome in Henoch-Schonlein nephritis in children and adults. Am J Kidney Dis 2006 ; 47 : 993-1003.
PubMed
9) Ronkainen J, Nuutinen M, Koskimies O : The adult kidney 24 years after childhood Henoch-Schonlein purpura : a retrospective cohort study. Lancet 2002 ; 360 : 666-670.
PubMed
10) Allen AC, Willis FR, Beattie TJ, et al. : Abnormal IgA glycosylation in Henoch-Schonlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 1998 ; 13 : 930-934.
PubMed
11) Pillebout E, Jamin A, Ayari H, et al. : Biomarkers of IgA vasculitis nephritis in children. PLoS One 2017 ; 12 : e0188718.
PubMed
12) Berthelot L, Jamin A, Viglietti D, et al. : Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort. Nephrol Dial Transplant 2018 ; 33 : 1579-1590.
 
13) Suzuki H, Moldoveanu Z, Julian BA, et al. : Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis. Kidney Int Rep 2019 ; 4 : 1717-1724.
PubMed
14) Williams CEC, Toner A, Wright RD, et al. : A systematic review of urine biomarkers in children with IgA vasculitis nephritis. Pediatr Nephrol 2021 ; 36 : 3033-3044.
PubMed
P.11 掲載の参考文献
1) Jennette JC, Falk RJ, Bacon PA, et al. : 2012 revised International Chapel Hill Consensus Conference Nomenclasture of Vasculitides. Arthritis Rheum 2013 ; 65 : 1-11.
 
2) Yang YH, Yu HH, Chiang BL : The diagnosis and classification of Henoch-Schonlein purpura : An updated review. Autoimmun Rev 2014 ; 13 : 355-358.
PubMed
3) Mills JA, Michel BA, Bloch DA, et al. : The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum 1990 ; 33 : 1114-1121.
PubMed
4) Ozen S, Ruperto N, Dillon MJ, et al. : EULAR/PReS endorsed consensus criteria for the classification childhood vasculitis, Ann Rheum Dis 2006 ; 65 : 936-941.
PubMed
a) 日本皮膚科学血管炎・血管障害診療ガイドライン改訂版作成委員会 : 血管炎・血管障害診療ガイドライン 2016年改訂版. 日皮会誌 2017 ; 127 : 299-415.
 
b) Ozen S, Marks SD, Brogan P, et al. : European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology 2019 ; 58 : 1607-1616.
 
P.14 掲載の参考文献
1) Lava SAG, Milani GP, Fossali EF, et al. : Cutaneous manifestations of small-vessel leukocytoclastic vasculitides in childhood. Clinic Rev Allerg Immunol 2017 ; 53 : 439-451.
 
2) Alkhater SA, Al Moaigel HM : Clinical spectrum, and outcome of immunoglobulin A vasculitis in children : A 10-year clinical study. Int J Clin Pract 2021 ; 75 : e13930.
PubMed
3) Milani GP, Lava SAG, Ramelli V, et al. : Prevalence and characteristics of non-blanching, palpable skin lesions with a linear pattern in children with Henoch-Schonlein syndrome. JAMA Dermatol 2017 ; 153 : 1170-1173.
 
4) Weiss PF : Pediatric vasculitis. Pediatr Clin N Am 2012 ; 59 : 407-423.
 
5) Akca UK, Batu ED, Serin O, et al. : Penile involvement of immunoglobulin A vasculitis/Henoch-Schonlein purpura. J Pediatr Urol 2021 ; 17 : 409.e1-409.e8.
 
6) Ramelli V, Lava SAG, Simonetti GD, et al. : Blistering eruptions in childhood Henoch-Schonlein syndrome : systematic review of the literature. Eur J Pediatr 2017 ; 176 : 487-492.
PubMed
7) Villatoro-Villar M, Crowson CS, Warrington KJ, et al. : Clinical characteristics of biopsy-proven IgA vasculitis in children and adults : A retrospective Cohort study. Mayo Clin Proc 2019 ; 4 : 1769-1780.
PubMed
8) Ting DV : Diagnosis and management of cutaneous cutaneous vasculitis in children. Pediatr Clin N Am 2014 ; 61 : 321-346.
 
P.17 掲載の参考文献
1) Ackerman AB : Leukocytoclastic vasculitis. In : Histologic Diagnosis of Inflammatory Skin Diseases, 2nd ed. Baltimore, Williams & Wilkins : 1997 ; 485-498.
 
2) Barksdale SK, Scampi P, et al. : Henoch-Schonlein purpura. In : Elder DE eds. Lever's Hitopathology of the skin, 11th ed. Philadelphia,Walters Kluwer : 2014 ; 256-257.
 
3) Patterson JW : Henoch-Schonlein purpura. In : Weedon's Skin Pathology, 5th ed. Elsevier : 2021 ; 258-259.
 
4) 川名誠司 : IgA血管炎. 川名誠司, 陳科榮 (編), 皮膚血管炎. 第2版, 医学書院, 2022 : 145-163.
 
5) 日本皮膚科学会血管炎・血管障害診療ガイドライン改訂版作成委員会 : IgA血管炎. 日皮会誌 : 2017 ; 127 : 332-340.
 
6) Ozen S, Ruperto N, Dillon MJ, et al. : EULAR/PreS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006 ; 65 : 936-941.
PubMed
7) Ozen S, Marks SD, Brogan P, et al. : European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 2019 ; 58 : 1607-1616.
PubMed
8) 川名誠司 : 皮膚IgM/IgG免疫複合体性血管炎. 川名誠司, 陳科榮 (編), 皮膚血管炎. 第2版, 医学書院, 2022 : 139-145.
 
9) 川名誠司 : 蕁麻疹様血管炎. 川名誠司, 陳科榮 (編), 皮膚血管炎. 第2版, 医学書院, 2022 : 164-171.
 
10) 川名誠司 : クリオグロブリン血症性血管炎. 川名誠司, 陳科榮 (編), 皮膚血管炎. 第2版, 医学書院, 2022 : 172-180.
 
P.20 掲載の参考文献
1) Wang X, Zhu Y, Gao L, et al. : Henoch-Schonlein purpura with joint involvement : Analysis of 71 cases. Pediatr Rheumatol Online J 2016 ; 14 : 20.
 
2) Petty RE, Laxer RM, Lindsley CB (Eds), et al. : Textbook of pediatric rheumatology, 8th ed, Elsevier, Philadelphia 2021 : 456-466.
 
3) Mooij CF, Hermsen R, Hoppenreijs EP, et al. : Fludeoxyglucose positron emission tomography-computed tomography scan showing polyarthritis in a patient with an atypical presentation of Henoch-Schonlein vasculitis without clinical signs of arthritis : a case report. J Med Case Rep 2016 ; 10 : 159.
 
4) 一般社団法人日本リウマチ学会・小児リウマチ調査小委員会 (編) : 若年性特発性関節炎 診療ハンドブック 2017. メディカルレビュー社, 2017 ; 41
 
5) Ronkainen J, Koskimies O, Ala-Houhala M, et al. : Early prednisone therapy in Henoch-Schonlein purpura : a randomized, double-blind, placebo-controlled trial. J Pediatr 2006 ; 149 : 241-247.
 
6) Jauhola O, Ronkainen J, Koskimies O, et al. : Clinical course of extrarenal symptoms in Henoch-Schonlein purpura : a 6-month prospective study. Arch Dis Child 2010 ; 95 : 871-876.
PubMed
P.22 掲載の参考文献
1) Ebert EC : Gastrointestinal manifestations of Henoch-Schonlein Purpura. Dig Dis Sci 2008 ; 53 : 2011-2019.
PubMed
2) Du L, Wang P, Liu C, et al. : Multisystemic manifestations of IgA vasculitis. Clin Rheumatol 2021 ; 40 : 43-52.
PubMed
3) Trnka P : Henoch-Schonlein purpura in children. J Paediatr Child Health 2013 ; 49 : 995-1003.
 
4) Rubino C, Monacelli C, Marrani E, et al. : Gastrointestinal involvement in IgA vasculitis : a single-center 11-year study on a cohort of 118 children. Clin Rheumatol 2021 ; 40 : 5041-5046.
 
5) Ozen S, Marks SD, Brogan P, et al. : European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 2019 ; 58 : 1607-1616.
PubMed
6) 阪上学, 野田八嗣, 越野慶隆 : 下血をみたSchonlein-Henoch紫斑病の1例における消化管粘膜病変の内視鏡的検討 本邦報告例32例の集計を含む. Gastroenterol Endosc 1988 ; 30 : 1250-1254.
 
7) 加藤順, 瀧真也 : IgA血管炎 (Schoenlein-Henoch 紫斑病). 【消化管症候群 (第3版) -その他の消化管疾患を含めて-】 空腸, 回腸, 盲腸, 結腸, 直腸 (上). 炎症性疾患, 日本臨床別冊消化管症候群 III. 2020 : 216-219.
 
8) 細江直樹, 市川理子, 宮永亮一, 他 : 【血管炎による消化管病変】 IgA血管炎における小腸カプセル内視鏡所見の検討. 胃と腸 2015 ; 50 : 1406-1410.
 
P.27 掲載の参考文献
1) Pacheva IH, Ivanov IS, Stefanova K, et al. : Central nervous system involvement in Henoch-Schonlein purpura in children and adolescents. Case Rep Pediatr 2017 : 5483543. doi : 10.1155/2017/5483543
 
2) Funken D, Gotz F, Bultmann E, et al. : Focal Seizures and posterior reversible encephalopathy syndrome as presenting signs of IgA vasculitis/Henoch-Schoenlein purpura-an educative case and systematic review of the literature. Front NeuRol 2021.759386. doi : 10,3389/fneur.2021.759386
 
3) Du L, Wang P, Liu C, et al. : Multisystemic manifestations of IgA vasculitis. Clin Rheumatol 2021 ; 40 : 43-52.
PubMed
4) Chiaretti A, Caresta E, Piastra M, et al. : Cerebral hemorrhage in Henoch-Schonlein syndrome. Childs Nerv Syst 2002 ; 18 : 365-367.
PubMed
5) Hamano H, Matsushige T, Inoue H, et al. : A case of acute encephalophathy with residual neurological sequelae induced by immunoglobulin A vasculitis. J Clin Neurosci 2019 ; 67 : 270-271.
PubMed
6) Lava SA, Peeters GG, Bianchetti MG, et al. : Posterior reversible encephalopathy syndrome in Henoch-Schonlein purpura. Rheumatol Int 2017 ; 37 : 461-463.
PubMed
7) Shin JI, Kim JH, Lee JS, et al. : Cardiac manifestations of Henoch-Schoenlein purpura : IgA mediated vasculitis or Rheumatic fever? Eur J Pediatr 2007 ; 166 : 627.
PubMed
8) Kang Z, Wu W, Xun M, et al. : Henoch-Schonlein Purpura/IgA Vasculitis Complicated by Coronary Artery Aneurysm : A Case Report and Literature Review. Front Pediatr 2022 Feb 3 ; 9 : 781106. doi : 10.3389/fped.2021.781106.
 
9) Yilmaz N, Yuksel S, Becerir T, et al. : Myocarditis and intracardiac thrombus due to Henoch-Schonlein purpura : case report and literature review. Clin Rheumatol 2021 ; 40 : 1635-1644.
PubMed
10) James CA, Gonzalez I, Khandhar P, et al. : Severe Mitral Regurgitation in a Child with Henoch-Schonlein Purpura and Pulmonary Hemorrhage. Glob Pediatr Health 2017 ; 4 : 2333794X17726940. doi : 10.1177/2333794X177 26940
 
11) Kalyoncu M, Cakir M, Erduran E, et al. : Henoch Schonlein purpura : a case with atypical presentation. Rheumatol Int 2006 ; 26 : 669-671.
PubMed
12) Monastiri K, Selmi H, Tabarki B, et al. : Primary antiphospholipid syndrome presenting as complicated Henoch-Schonlein purpura. Arch Dis Child 2002 ; 86 : 132-133.
PubMed
13) Topaloglu R, Bayrakci US, Cil B, et al. : Henoch-Schonlein purpura with high factor VIII levels and deep venous thrombosis : an association or coincidence? Rheumatol Int 2008 ; 28 : 935-937.
PubMed
14) Li L, Zhang J, Zhang Y, et al. : Thrombosis warning in children suffering from henoch-schonlein purpura. Indian J Dermatol 2013 ; 58 : 409.
 
15) Abidin ASZ, Jalaluddin MY : Left hand compartment syndrome : a rare complication of Henoch Schonlein purpura. J Paediatr Child Health 2008 ; 44 : 385.
PubMed
16) Zheng C, Childers J, Rabinovich E, et al. : Recurrent Henoch-Schonlein Purpura with bullous rash and pulmonary nodules. Pediatr Rheumatol Online J 2020 ; 18 : 40.
PubMed
17) Cazzato S, Bernardi F, Cinti C, et al. : Pulmonary function abnormalities in children with HenochSchonlein purpura. Eur Respir J 1999 ; 13 : 597-601.
PubMed
18) Duan H, Hua Y, Zhou K, et al. : A delayed diagnosis of late-onset pulmonary hemorrhage in a toddler with Henoch-Schonlein purpura after regression of skin rash : A case report and literature review. Medicine (Baltimore) 2020 ; 99 : e23025.
 
19) Di Pietro GM, Castellazzi ML, Mastrangelo A, et al. : Henoch-Schonlein purpura in children : not only kidney but also lung. Pediatr Rheumatol Online J 2019 ; 17 : 75.
 
20) Zhang Q, Guo Q, Gui M, et al. : Henoch-Schonlein purpura with acute pancreatitis : analysis of 13 cases. BMC Pediatr 2018 ; 18 : 159.
 
21) Helbling R, Lava SA, Simonetti GD, et al. : Gallbladder and pancreas in Henoch-Schonlein Purpura : review of the literature. J Pediatr Gastroenterol Nutr 2016 ; 62 : 457-461.
PubMed
22) Siomou E, Serbis A, Salakos C, et al. : Masked severe stenosing ureteritis : a rare complication of Henoch-Schonlein purpura. Pediatr Nephrol 2008 ; 23 : 821-825.
PubMed
23) Modi S, Mohan M, Jennings A : Acute scrotal swelling in henoch-schonlein purpura : case report and review of the literature. Urol Case Rep 2016 ; 6 : 9-11.
PubMed
24) Ma Y, Zhang S, Chen J, et al. : Henoch-Schonlein Purpura With Scrotal Involvement : A Case Report and Literature Review. J Pediatr Hematol Oncol 2021 ; 43 : 211-215.
 
25) Brodie A, Natasha G, Nitiahpapand R, et al. : Unusual presentation of Henoch-Schonlein purpura. BMJ Case Rep 2018 ; 2018 : bcr2017220129.
PubMed
26) Ozen S, Marks SD, Brogan P, et al. : European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 2019 ; 58 : 1607-1616.
PubMed
27) Kaya Akca U, Batu ED, Serin O, et al. : Penile involvement of immunoglobulin a vasculitis/Henoch-Schonlein purpura. J Pediatr Urol 2021 ; 17 : 409.e1-409.e8.
 
28) Aypar E, Demirtas D, Aykan HH, et al. : A girl with Henoch Schonlein purpura associated with acute rheumatic fever and review of literature. Turk J Pediatr 2018 ; 60 : 576-580.
PubMed
29) Guven H, Ozhan B, Bakiler AR, et al. : A case of Henoch Schonlein purpura and rheumatic carditis with complete atrioventricular block. Eur J Pediatr 2006 ; 165 : 395-397.
PubMed
30) Murata C, Rodriguez-Lozano AL, Hernandez-Huirache HG, et al. : IgA vasculitis (Henoch-Schonlein Purpura) as the first manifestation of juvenile Systemic Lupus Erythematosus : Case-control study and systematic review. BMC Pediatr 2019 : 19 ; 461.
 
P.32 掲載の参考文献
1) 日本皮膚科学血管炎・血管障害診療ガイドライン改訂版作成委員会 : 血管炎・血管障害診療ガイドライン 2016年改訂版. 日皮会誌 2017 ; 127 : 299-415.
 
2) Ronkainen J, Koskimies O, Ala-Houhala M, et al. : Early prednisone therapy in Henoch-Schonlein purpura : a randomized, double-blind, placebo-controlled trial. J Pediatr 2006 ; 149 : 241-247.
 
3) Pyne D, Mootoo R, Bhanji A : Colchicine for the treatment of recurrent Henoch-Schonlein purpura in an adult. Rheumatology (Oxford). 2001 ; 40 : 1430-1431.
 
4) Roman C, Dima B, Muyshont L, et al. : Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura) : case series and a review of the literature. Eur J Pediatr 2019 ; 178 : 1275-1281.
 
5) Iqbal H, Evans A : Dapsone therapy for Henoch-Schonlein purpura : a case series. Arch Dis Child 2005 ; 90 : 985-986.
PubMed
6) Fukui H, Kamitsuji H, Nagao T, et al. : Clinical evaluation of a pasteurized factor XIII concentrate administration in Henoch-Schonlein purpura. Japanese Pediatric Group. Thromb Res 1989 ; 56 : 667-675.
 
7) Narin N, Akcoral A, Aslin MI, et al. : Ranitidine administration in Henoch-Schonlein vasculitis. Acta Paediatr Jpn 1995 ; 37 : 37-39.
PubMed
8) 前田太郎, 宮本元, 小城崇弘, 他 : H2-blockerが有効であった十二指腸潰瘍を合併するアレルギー性紫斑病. 小児科診療 1999 ; 62 : 1084-1086.
 
9) Yoshida M, Nambu R, Yasuda R, et al. : Dapsone for refractory gastrointestinal symptoms in Children with immunoglobulin A vasculitis. Pediatrics 2022 ; 150 : e2021055884.
PubMed
10) 永野千代子 : IgA血管炎. 特集 : 病巣感染 III. 口腔・咽頭の原病巣が関連する疾患. 小児疾患, 日本臨牀 2021 ; 79 : 1000-1007.
 
a) Hetland LE, Susrud KS, Lindahl KH, et al. : Henoch-Schonlein Purpura : A Literature Review. Acta Derm Venereol 2017 ; 97 : 1160-1166.
PubMed
b) Ozen S, Marks SD, Brogan P, et al. : European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 2019 ; 58 : 1607-1616.
 
c) Lee KH, Hong SH, Jun J, et al. : Treatment of refractory IgA vasculitis with dapsone : a systematic review. Clin Exp Pediatr 2020 ; 63 : 158-163.
 
P.36 掲載の参考文献
1) Henoch EH. Vorlesungen uber kinderkranheiten. In : Hirschward A, ed. Vorlesungen uber kinderkranheiten. Berlin : Aufl, 1899 : 839.
 
2) Ozen S, Marks SD, Brogan P, et al. : European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 2019 ; 58 : 1607-1616.
PubMed
3) Calvino MC, Llorca J, Garcia-Porrua C, et al. : Henoch-Schonlein purpura in children from northwestern Spain : a 20-year epidemiologic and clinical study. Medicine (Baltimore) 2001 ; 80 : 279-290.
 
4) Saulsbury FT : Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 1999 ; 78 : 395-409.
PubMed
5) Narchi H : Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings : a systematic review. Arch Dis Child 2005 ; 90 : 916-920.
PubMed
6) Goldstein AR, White RH, Akuse R, et al. : Long-term follow-up of childhood Henoch-Schonlein nephritis. Lancet 1992 ; 339 : 280-282.
PubMed
7) Coppo R, Mazzucco G, Cagnoli L, et al. : Long-term prognosis of Henoch-Schonlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schonlein purpura. Nephrol Dial Transplant 1997 ; 12 : 2277-2283.
 
8) Scharer K, Krmar R, Querfeld U, et al. : Clinical outcome of Schonlein-Henoch purpura nephritis in children. Pediatr Nephrol 1999 ; 13 : 816-823.
PubMed
9) Davin JC, Coppo R : Henoch-Schonlein purpura nephritis in children. Nat Rev Nephrol 2014 ; 10 : 563-573.
PubMed
10) Stewart M, Savage JM, Bell B, et al. : Long term renal prognosis of Henoch-Schonlein purpura in an unselected childhood population. Eur J Pediatr 1988 ; 147 : 113-115.
 
11) Kawasaki Y, Suyama K, Yugeta E, et al. : The incidence and severity of Henoch-Schonlein purpura nephritis over a 22-year period in Fukushima Prefecture, Japan. Int Urol Nephrol 2010 ; 42 : 1023-1029.
 
12) Terano C, Hamada R, Tatsuno I, et al. : Epidemiology of biopsy-proven Henoch-Schonlein purpura nephritis in children : A nationwide survey in Japan. PLOS One 2022 ; 17 : e0270796.
PubMed
13) Sugiyama H, Yokoyama H, Sato H, et al. : Japan Renal Biopsy Registry and Japan Kidney Disease Registry : Committee Report for 2009 and 2010. Clin Exp Nephrol 2013 ; 17 : 155-173.
PubMed
14) Ozen S, Pistorio A, Iusan SM, et al. : EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis : Ankara 2008. Part II : Final classification criteria. Ann Rheum Dis 2010 ; 69 : 798-806.
PubMed
15) Piram M, Maldini C, Biscardi S, et al. : Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis : a population-based study. Rheumatology (Oxford) 2017 ; 56 : 1358-1366.
PubMed
16) Sapina M, Frkovic M, Sestan M, et al. : Geospatial clustering of childhood IgA vasculitis and IgA vasculitis-associated nephritis. Ann Rheum Dis 2021 ; 80 : 610-616.
PubMed
17) Levinsky RJ, Barratt TM : IgA immune complexes in Henoch-Schonlein purpura. Lancet 1979 ; 2 : 1100-1103.
PubMed
18) Lau KK, Suzuki H, Novak J, et al. : Pathogenesis of Henoch-Schonlein purpura nephritis. Pediatr Nephrol 2010 ; 25 : 19-26.
 
19) Hastings MC, Rizk DV, Kiryluk K, et al. : IgA vasculitis with nephritis : update of pathogenesis with clinical implications. Pediatr Nephrol 2022 ; 37 : 719-733.
PubMed
20) Lau KK, Wyatt RJ, Moldoveanu Z, et al. : Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schonlein purpura. Pediatr Nephrol 2007 ; 22 : 2067-2072.
PubMed
21) Pillebout E, Jamin A, Ayari H, et al. : Biomarkers of IgA vasculitis nephritis in children. PLoS One 2017 ; 12 : e0188718.
PubMed
22) Mizerska-Wasiak M, Gajewski L, Cichon-Kawa K, et al. : Serum GDIgA1 levels in children with IgA nephropathy and Henoch-Schonlein nephritis. Cent Eur J Immunol 2018 ; 43 : 162-167.
PubMed
23) Suzuki H, Moldoveanu Z, Julian BA, et al. : Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis. Kidney Int Rep 2019 ; 4 : 1717-1724.
PubMed
24) Suzuki H, Yasutake J, Makita Y, et al. : IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int 2018 ; 93 : 700-705.
PubMed
25) Evans DJ, Williams DG, Peters DK, et al. : Glomerular deposition of properdin in Henoch-Schonlein syndrome and idiopathic focal nephritis. Br Med J 1973 ; 3 : 326-328.
PubMed
26) Wyatt RJ, Kanayama Y, Julian BA, et al. : Complement activation in IgA nephropathy. Kidney Int 1987 ; 31 : 1019-1023.
PubMed
27) Oortwijn BD, Eijgenraam JW, Rastaldi MP, et al. : The role of secretory IgA and complement in IgA nephropathy. Semin Nephrol 2008 ; 28 : 58-65.
PubMed
28) Moura IC, Benhamou M, Launay P, et al. : The glomerular response to IgA deposition in IgA nephropathy. Semin Nephrol 2008 ; 28 : 88-95.
PubMed
29) Masuda M, Nakanishi K, Yoshizawa N, et al. : Group A streptococcal antigen in the glomeruli of children with Henoch-Schonlein nephritis. Am J Kidney Dis 2003 ; 41 : 366-370.
 
30) Namgoong MK, Lim BK, Kim JS : Eosinophil cationic protein in Henoch-Schonlein purpura and in IgA nephropathy. Pediatr Nephrol 1997 ; 11 : 703-706.
PubMed
31) Kawasaki Y, Imaizumi T, Matsuura H, et al. : Renal expression of alpha-smooth muscle actin and c-Met in children with Henoch-Schonlein purpura nephritis. Pediatr Nephrol 2008 ; 23 : 913-919.
 
32) Lopez-Mejias R, Carmona FD, Castaneda S, et al. : A genome-wide association study suggests the HLA Class II region as the major susceptibility locus for IgA vasculitis. Sci Rep 2017 ; 7 : 5088.
 
33) Koskela M, Nihtila J, Ylinen E, et al. : HLA-DQ and HLA-DRB1 alleles associated with Henoch-Schonlein purpura nephritis in Finnish pediatric population : a genome-wide association study. Pediatr Nephrol 2021 ; 36 : 2311-2318.
PubMed
a) 日本小児腎臓病学会 : 小児IgA腎症診療ガイドライン 2020. 診断と治療社, 2020
 
P.40 掲載の参考文献
1) Jennette JC, Falk RJ, Bacon PA, et al. : 2012 revised International Chapel Hill Consensus Conference Nomenclasture of Vasculitides. Arthritis Rheum 2013 ; 65 : 1-11.
 
2) Ozen S, Pistroio A, Lusan SM, et al. : EULAR/PRINTO/PRES criteria of Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis : Ankara 2008. Part II : Final classification criteria. Ann Rheum Dis 2010 ; 69 : 798-806.
 
3) Ozen S, Marks SD, Brogan P, et al. : European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 2019 ; 58 : 1607-1616.
PubMed
4) Terano C, Hamada R, Tatsuno I, et al. : Epidemiology of biopsy-proven Henoch-Schonlein purpura nephritis in children : A nationwide survey in Japan. PLoS One 2022 ; 17 : e0270796.
PubMed
5) Jennette JC, Silva FG, Olson JL, et al. (eds.) : Heptinstall's Pathology of The Kidney, 7th ed, Wolters Kluwer. Philadelphia, 2015 : 463-523.
 
P.43 掲載の参考文献
1) Shi D, Chan H, Yang X, et al. : Risk factors associated with IgA vasculitis with nephritis (Henoch-Schonlein purpura nephritis) progressing to unfavorable outcomes : A meta-analysis. PLoS One 2019 ; 14 : e0223218.
 
2) Counahan R, Winterborn MH, White RH, et al. : Prognosis of Henoch-Schonlein nephritis in children. Br Med J 1977 ; 2 : 11-14.
PubMed
3) Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, et al. : The Oxford classification of IgA nephropathy : rationale, clinicopathological correlations, and classification. Kidney Int 2009 ; 76 : 534-545.
 
4) Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, et al. : The Oxford classification of IgA nephropathy : pathology definitions, correlations, and reproducibility. Kidney Int 2009 ; 76 : 546-556.
 
5) Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Coppo R, Troyanov S, et al. : The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults. Kidney Int 2010 ; 77 : 921-927.
 
6) Trimarchi H, Barratt J, Cattran DC, et al. : Oxford Classification of IgA nephropathy 2016 : an update from the IgA Nephropathy Classification Working Group. Kidney Int 2017 ; 91 : 1014-1021.
 
7) Huang X, Ma L, Ren P, et al. : Updated Oxford classification and the international study of kidney disease in children classification : application in predicting outcome of Henoch-Schonlein purpura nephritis. Diagn Pathol 2019 ; 14 : 40.
 
8) Yun D, Kim DK, Oh KH, et al. : MEST-C pathological score and long-term outcomes of child and adult patients with Henoch-Schonlein purpura nephritis. BMC Nephrol 2020 ; 21 : 33.
 
9) Barbour SJ, Coppo R, Er L, et al. : Updating the International IgA Nephropathy Prediction Tool for use in children. Kidney Int 2021 ; 99 : 1439-1450.
PubMed
a) Nakanishi K, Yoshikawa N : Immunoglobulin A nephropathy in children (Includes HSP). In : Pediatric Nephrology, 7th ed, Avner ED, et al. (eds), Springer, Heidelberg, 2016 : 983-1033.
 
P.48 掲載の参考文献
1) Ozen S, Marks SD, Brogan P, et al. : European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 2019 ; 58 : 1607-1616.
PubMed
2) Thompson A, Carroll K, A Inker L, et al. : Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy. Clin J Am Soc Nephrol 2019 ; 14 : 469-481.
 
3) Terano C, Hamada R, Tatsuno I, et al. : Epidemiology of biopsy-proven Henoch-Schonlein purpura nephritis in children : A nationwide survey in Japan. PLoS One 2022 ; 17 : e0270796.
PubMed
4) Nagai S, Horinouchi T, inchoji T, et al. : Use of renin-angiotensin system inhibitors as initial therapy in children with Henoch-Schonlein purpura nephritis of moderate severity. Pediatr Nephrol 2022 ; 37 : 1845-1853.
 
5) Delbet JD, Hogan J, Aoun B, et al. : Clinical outcomes in children with Henoch-Schonlein purpura nephritis without crescents. Tim Ulinski Pediatr Nephrol 2017 ; 32 : 1193-1199.
PubMed
6) Park JM, Won SC, Shin JI, et al. : Cyclosporin A therapy for Henoch-Schonlein nephritis with nephrotic-range proteinuria. Pediatr Nephrol 2011 ; 26 : 411-417.
PubMed
7) Kasahara K, Gotoh Y, Kuroyanagi Y, et al. : Steroid-and immunosuppressant-based protocol of Henoch-Schonlein purpura nephritis without angiotensin inhibitors in the acute phase : case series with correlation to histology. Minerva Pediatr 2018 Nov 7. doi : 10.23736/S0026-4946.18.05324-0.
 
8) Kurt-Sukur ED, Sekar T, Tullus K : Biopsy-proven Henoch-Schonlein purpura nephritis : a single center experience. Pediatr Nephrol 2021 ; 36 : 1207-1215.
PubMed
9) Umeda C, Fujinaga S, Endo A, et al. : Preventive Effect of Tonsillectomy on Recurrence of Henoch-Schonlein Purpura Nephritis after Intravenous Methylprednisolone Pulse Therapy. Tohoku J Exp Med 2020 ; 250 : 61-69.
PubMed
10) Ninchoji T, Kaito H, Nozu K, et al. : Treatment strategies for Henoch-Schonlein purpura nephritis by histological and clinical severity. Pediatr Nephrol 2011 ; 26 : 563-569.
PubMed
11) Davin JC, Rosanna Coppo R : Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch-Schonlein purpura nephritis. Pediatr Nephrol 2013 ; 28 : 1897-1903.
 
a) 成田一衛 (監), 厚生労働科学研究費補助金難治性疾患等政策研究事業 (難治性疾患政策研究事業) 難治性腎障害に関する調査研究班 (編) : エビデンスに基づくIgA腎症診療ガイドライン 2020. 東京医学社, 2020.
 

II クリニカルクエスチョン ( CQ )

P.53 掲載の参考文献
1) Paul SS, Scalzi LV : Exercise-Induced Purpura in Children. Pediatrics 2019 ; 143 : e20182797.
PubMed
2) Ponce de Souza E, Usatine RP : Palpable purpura and a visible sock line. J Fam Pract 2005 ; 54 : 520-523.
 
3) Kelly RI, Opie J, Nixon R : Golfer's vasculitis. Australas J Dermatol 2005 ; 46 : 11-14.
PubMed
4) Robson WL, Leung AK, Lemay M : The pressure-dependent nature of the rash in Henoch Schonlein purpura. J Singapore Paediatr Soc 1992 ; 34 : 230-231.
PubMed
P.56 掲載の参考文献
1) Sivaraman V, Fels EC, Ardoin SP : Henoch-Schonlein purpura. Kliegman RM, St Geme JW 3rd, Blum NJ, et al. (eds.) Nelson Textbook of Pediatrics, 21st ed. 2020 : 1318-1320.
 
2) 五十嵐徹, 高山良子 : IgA血管炎. 小児リウマチ学会 (編) : 小児リウマチ学. 朝倉書店, 2020 : 189-192.
 
3) 山下泰正, 他 : 紫斑病に対するアドナの治療効果. 新薬と臨牀 1956 ; 5 : 663-669.
Medical*Online
4) Prandota J, Pankow-Prandota L, otecki L, et al. : Impaired activation of the fibrinolytic system in children with Henoch-Schonlein purpura : beneficial effect of hydrocortisone plus Σ-aminocaproic acid therapy on disappearance rate of cutaneous vasculitis and fibrinolysis. Am J Ther 2001 ; 8 : 11-19.
 
5) Okamoto S, Nakajima T, Okamoto U, et al. : A suppressing effect of ε-amino-n-caproic acid on the bleeding of dogs, produced with the activation of plasmin in the circulatory blood. Keio J Med 1959 ; 8 : 247-266.
 
6) Okamoto S, Okamoto U : Amino-methyl-cyclohexane-carboxylic acid : AMCHA a new potent inhibitor of the fibrinolysis. Keio J Med 1962 ; 11 : 105-115.
 
P.59 掲載の参考文献
1) Ozen S, Marks SD, Brogan P, et al. : European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 2019 ; 58 : 1607-1616.
PubMed
2) Ronkainen J, Koskimies O, Ala-Houhala M, et al. : Early prednisone therapy in Henoch-Schonlein purpura : a randomized, double-blind, placebo-controlled trial. J Pediatr 2006 ; 149 : 241-247.
 
3) Jauhola O, Ronkainen J, Koskimies O, et al. : Clinical course of extrarenal symptoms in Henoch-Schonlein purpura : a 6-month prospective study. Arch Dis Child 2010 ; 95 : 871-876.
PubMed
4) Deng F, Lu L, Zhang Q, et al. : Henoch-Schonlein purpura in childhood : treatment and prognosis. Analysis of 425 cases over a 5-year period. Clin Rheumatol 2010 ; 29 : 369-374.
 
5) Masarweh K, Horovitz Y, Avital A, et al. : Establishing hospital admission criteria of pediatric Henoch-Schonlein purpura. Rheumatol Int 2014 ; 34 : 1497-1503.
PubMed
6) Wang X, Zhu Y, Gao L, et al. : Henoch-Schonlein purpura with joint involvement : Analysis of 71 cases. Pediatr Rheumatol Online J 2016 ; 14 : 20.
 
P.61 掲載の参考文献
1) Huber AM, King J, McLaine P, et al. : A randomized, placebo-controlled trial of prednisone in early Henoch Schonlein Purpura [ISRCTN85109383]. BMC Med 2004 ; 2 : 7.
PubMed
2) Ronkainen J, Koskimies O, Ala-Houhala M, et al. : Early prednisone therapy in Henoch-Schonlein purpura : a randomized, double-blind, placebo-controlled trial. J Pediatr 2006 ; 149 : 241-247.
 
3) Rosenblum ND, Winter HS : Steroid effects on the course of abdominal pain in children with Henoch-Schonlein purpura. Pediatrics 1987 ; 79 : 1018-1021.
PubMed
4) Dawod ST, Akl KF : Henoch-Schoenlein syndrome in Qatar : the effects of steroid therapy and paucity of renal involvement. Ann Trop Paediatr 1990 ; 10 : 279-284.
PubMed
5) Reinehr T, Burk G, Andler W : Does steroid treatment of abdominal pain prevent renal involvement in Henoch-Schonlein purpura? J Pediatr Gastroenterol Nutr 2000 ; 31 : 323-324.
PubMed
6) Weiss PF, Klink AJ, Localio R, et al. : Corticosteroids may improve clinical outcomes during hospitalization for Henoch-Schonlein purpura. Pediatrics 2010 ; 126 : 674-681.
PubMed
a) Ozen S, Marks SD, Brogan P, et al. : European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 2019 ; 58 : 1607-1616.
PubMed
b) Abu-Zaid MH, Salah S, Lotfy HM, et al. : Consensus evidence-based recommendations for treat-to-target management of immunoglobulin A vasculitis. Ther Adv Musculoskelet Dis 2021 ; 13 : 1759720X211059610.
 
P.64 掲載の参考文献
1) Fukui H, Kamitsuji H, Nagao K, et al. : Clinical evaluation of a pasteurized factor XIII concentrate administration in Henoch-Schonlein purpura. Japanese Pediatric Group. Thromb Res 1989 ; 15 : 667-675.
 
2) 長尾大 : 血管性紫斑病に対する凝固第13因子. 小児科 1993 ; 34 : 643-647.
 
3) Matayoshi T, Omi T, Sakai N, et al. : Clinical significance of blood coagulation factor XIII activity in adult Henoch-Schonlein purpura. J Nippon Med Sch 2013 ; 80 : 268-278.
PubMed
4) Utani A, Ohta M, Shinya A, et al. : Successful treatment of adult Henoch-Schonlein purpura with factor XIII concentrate. J Am Acad Dermatol 1991 ; 24 : 438-442.
PubMed
5) Prenzel F, Pfaffle R, Thiele F, et al. : Decreased factor XIII activity during severe Henoch-Schoenlein purpura--does it play a role? Klin Padiatr 2006 ; 218 : 174-176.
PubMed
6) Sonbul AA, Noor A, Ahmed N, et al. : Successful treatment of severe gastrointestinal manifestations of Henoch-Schonlein Purpura and factor XIII deficiency using cryoprecipitate transfusion. Int J Pediatr Adolesc Med 2015 ; 2 : 84-88.
 
7) 佐々木信彦, 高見沢重隆, 藤沢康司, 他 : 第13因子補充療法を施行した難治性アナフィラクトイド紫斑病の1例. 小児科診療 1987 ; 50 : 1256-1260.
 
8) 坂田宏, 佐藤敬, 平野至規, 他 : 血管性紫斑病に対する乾燥濃縮人血液凝固第13因子製剤の有用性の臨床的検討. 臨床小児医学 1993 ; 41 : 119-122.
 
9) Murata M, Yamazaki Y, Shimogama T, et al. : Immunoglobulin A vasculitis without purpura in an elderly female patient : a case report. Clin J Gastroenterol 2021 ; 14 : 1090-1095.
 
10) Ando K, Fujiya M, Sugiyama R, et al. : Atypical tumour-like involvement of the colon in Henoch-Schonlein purpura successfully treated with the administration of factor XIII. BMJ Case Rep 2011 ; 12 : bcr0820103251.
 
11) Nakayama N, Nagata S, Kawase R, et al. : A case of Henoch-Scholein purpura with acute pancreatitis. Nihon Shokakibyo Gakkai Zasshi 2009 ; 106 : 240-246.
PubMed
12) Kamitsuji H, Tani K, Yasui M, et al. : Activity of blood coagulation factor XIII as a prognostic indicator in patients with Henoch-Schonlein purpura. Efficacy of factor XIII substitution. Eur J Pediatr 1987 ; 146 : 519-523.
PubMed
13) Henriksson P, Hedner U, Nilsson IM : Factor XIII (fibrin stabilising factor) in Henoch-Schonlein's purpura. Acta Paediatr Scand 1977 ; 66 : 273-277.
PubMed
14) 齋藤正博, 大友義之, 大日方薫, 他 : Schonlein-Henoch purpuraにおける第XIII因子濃縮製剤 (Fibrogammin(R)) の使用経験. 小児科診療 1994 ; 57 : 325-330.
 
15) 小山哲哉, 山下和子, 阿達恒一 : 当科におけるHenoch-Schonlein purpuraに対する血液凝固第XIII因子製剤の臨床評価. 小児科 1994 ; 35 : 173-176.
 
16) 泉信夫, 田草雄一, 大家隆晴, 他 : 血液凝固第XIII因子製剤を投与したSchonlein-Henoch紫斑病の2症例. 島根医学 1993 ; 13 : 27-31.
 
17) 福井弘, 上辻秀和, 長尾大, 他 : 小児Henoch-Schonlein Purpuraに対するPasteurized Factor XIII Concentrate投与後の長期経過. 小児科臨床 1992 ; 45 : 2232-2238.
Medical*Online
18) 平泉泰久, 近藤富雄, 安田寛二, 他 : Schonlein-Henoch Purpura急性期の第XIII因子活性の臨床的検討および第XIII因子製剤 (Fibrogammin(R) P) の使用経験. 新薬と臨床 1992 ; 41 : 332-338.
 
19) Koshiba K, Muraoka S, Nanki T, et al. : Successful Treatment of IgA Vasculitis Complicated with Bowel Perforation and Crescentic Glomerulonephritis by Combination Therapy of Glucocorticoid, Cyclosporine and Factor XIII Replacement. Intern Med 2018 ; 57 : 3035-3040.
PubMed
20) Kawasaki K, Komura H, Nakahara Y, et al. : Factor XIII in Henoch-Schonlein purpura with isolated gastrointestinal symptoms. Pediatr Int 2006 ; 48 : 413-415.
PubMed
21) Migita M, Hayakawa J, Shima H, et al. : A case of Henoch-Schonlein purpura with rare complications : necrosis of the small intestine, neurological symptoms, and pericardial tamponade. J Nippon Med Sch 2005 ; 72 : 383-386.
PubMed
22) Shimomura N, Kawai K, Watanabe S, et al. : Adult Henoch-Schonlein purpura with severe abdominal pain treated with dapsone and factor XIII concentrate. J Dermatol 2005 ; 32 : 124-127.
PubMed
23) Nakahata T, Tanaka H, Suzuki K, et al. : Successful treatment with leukocytapheresis in refractory Henoch-Schonlein purpura : case report. Clin Rheumatol 2003 ; 22 : 248-250.
PubMed
P.67 掲載の参考文献
1) Narin N, Akcoral A, Aslin MI, et al. : Ranitidine administration in Henoch-Schonlein vasculitis. Acta Paediatr Jpn 1995 ; 37 : 37-39.
PubMed
2) Ebert EC : Gastrointestinal manifestations of Henoch-Schonlein Purpura. Dig Dis Sci 2008 ; 53 : 2011-2019.
PubMed
3) 前田太, 宮本元, 小城崇, 他 : H2-blockerが有効であった十二指腸潰瘍を合併したアレルギー性紫斑病. 小児科診療 1999 ; 62 : 1084-1086.
 
P.72 掲載の参考文献
1) Dedeoglu F, Kim S : IgA vasculitis (Henoch-Schonlein purpura) : Management. In : UpToDate, Sundel R (ed.). UpToDate. Waltham, MA.〔https://www.uptodate.com/contents/iga-vasculitis-henoch-schonlein-purpura-management?search=IgA%20vasculitis%20Management&source=search_result&selectedTitle=1~112&usage_type=default&display_rank=1〕 <閲覧日 2022.4.13>
 
2) 日本循環器学会, 他 : 血管炎症候群の診療ガイドライン (2017年改訂版). 〔https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2017_isobe_h.pdf〕 <閲覧日 2022.4.13>
 
3) Ozen S, Marks SD, Brogan P, et al. : European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 2019 ; 58 : 1607-1616.
PubMed
4) Kang HS, Chung HS, Kang KS, et al. : High-dose methylprednisolone pulse therapy for treatment of refractory intestinal involvement caused by Henoch-Schonlein purpura : a case report. J Med Case Rep 2015 ; 9 : 65.
PubMed
5) Wang L, Huang FC, Ko SF, et al. : Successful treatment of mesenteric vasculitis caused by Henoch-Schonlein purpura with methylprednisolone pulse therapy. Clin Rheumatol 2003 ; 22 : 140-142.
PubMed
6) Agras PI, Guveloglu M, Aydin Y, et al. : Lower brachial plexopathy in a child with Henoch-Schonlein purpura. Pediatr Neurol 2010 ; 42 : 355-358.
 
7) Akcaboy M, Fidan K, Kandur Y, et al. : Cerebral Vasculitis in Henoch-Schonlein Purpura : A Case Report. Arch Rheumatol 2017 ; 32 : 264-267.
PubMed
8) Zuniga C, Diaz S, Farina A, et al. : Remission of concomitant Henoch-Schoenlein purpura and Sydenham chorea after intravenous corticosteroids. Neurol India 2009 ; 57 : 55-57.
PubMed
9) Kano K, Ozawa T, Kuwashima S, et al. : Uncommon multisystemic involvement in a case of Henoch-Schonlein purpura. Acta Paediatr Jpn 1998 ; 40 : 159-161.
 
10) Bulun A, Topaloglu R, Duzova A, et al. : Ataxia and peripheral neuropathy : rare manifestations in Henoch-Schonlein purpura. Pediatr Nephrol 2001 ; 16 : 1139-1141.
PubMed
11) Bakkaloglu SA, Ekim M, Tumer N, et al. : Cerebral vasculitis in Henoch-Schonlein purpura. Nephrol Dial Transplant 2000 ; 15 : 246-248.
PubMed
12) Zhang Q, Guo Q, Gui M, et al. : Henoch-Schonlein purpura with acute pancreatitis : analysis of 13 cases. BMC Pediatr 2018 ; 18 : 159.
 
13) Wang L, Ni SW, Deng F, et al. : Rare presentation of immunoglobulin A vasculitis as acute pancreatitis in a 10-year-old girl. J Paediatr Child Health 2019 ; 55 : 597-600.
 
14) Zheng C, Childers J, Rabinovich E, et al. : Recurrent Henoch-Schonlein Purpura with bullous rash and pulmonary nodules. Pediatr Rheumatol Online J 2020 ; 18 : 40.
PubMed
15) Ben-Chaim J, Korat E, Shenfeld O, et al. : Acute scrotum caused by Henoch-Schonlein purpura, with immediate response to short-term steroid therapy. J Pediatr Surg 1995 ; 30 : 1509-1510.
PubMed
16) Migita M, Hayakawa J, Shima H, et al. : A case of Henoch-Schonlein purpura with rare complications : necrosis of the small intestine, neurological symptoms, and pericardial tamponade. J Nippon Med Sch 2005 ; 72 : 383-386.
PubMed
17) Chen SY, Chang KC, Yu MC, et al. : Pulmonary hemorrhage associated with Henoch-Schonlein purpura in pediatric patients : case report and review of the literature. Semin Arthritis Rheum 2011 ; 41 : 305-312.
PubMed
18) Dhaliwal KK, Lile NA, Tan CL, et al. : Life-threatening complications of Henoch-Schonlein purpura : diffuse alveolar haemorrhage, venous thrombosis and bowel ischaemia. BMJ Case Rep 2020 ; 13 : e235905.
PubMed
19) Matsubayashi R, Matsubayashi T, Fujita N, et al. : Pulmonary hemorrhage associated with Henoch-Schonlein purpura in a child. Clin Rheumatol 2008 ; 27 : 803-805.
 
20) Besbas N, Duzova A, Topaloglu R, et al. : Pulmonary haemorrhage in a 6-year-old boy with Henoch-Schonlein purpura. Clin Rheumatol 2001 ; 20 : 293-296.
 
21) 日本小児腎臓病学会 (監修), 難治性疾患政策研究事業「小児腎領域の希少・難治性疾患群の診療・研究体制の確立」 (厚生労働科学研究費補助金) 作成 : 小児特発性ネフローゼ症候群診療ガイドライン 2020. 診断と治療社, 2020.
 
22) Heldrich FJ, Minkin S, Gatdula CL : Intravenous immunoglobulin in Henoch-Schonlein purpura : a case study. Md Med J 1993 ; 42 : 577-579.
PubMed
23) Morotti F, Bracciolini G, Caorsi R, et al. : Intravenous immunoglobulin for corticosteroid-resistant intestinal Henoch-Schonlein purpura : worth a controlled trial against corticosteroids? Rheumatology (Oxford) 2021 ; 60 : 3868-3871.
 
24) Naifa G, Totikidis G, Alexiadou S, et al. : Intravenous γ Globulin for Intractable Abdominal Pain due to IgA Vasculitis. Case Rep Pediatr 2020 ; 2020 : 8867621.
 
25) Fagbemi AA, Torrente F, Hilson AJ, et al. : Massive gastrointestinal haemorrhage in isolated intestinal Henoch-Schonlein purpura with response to intravenous immunoglobulin infusion. Eur J Pediatr 2007 ; 166 : 915-919.
PubMed
26) Lamireau T, Rebouissoux L, Hehunstre JP, et al. : Intravenous immunoglobulin therapy for severe digestive manifestations of Henoch-Schonlein purpura. Acta Paediatr 2001 ; 90 : 1081-1082.
PubMed
27) Cherqaoui B, Chaussetet A, Stephan JL, et al. : Intravenous immunoglobulins for severe gastrointestinal involvement in pediatric Henoch-Schonlein purpura : A French retrospective study. Arch Pediatr 2016 ; 23 : 584-590.
 
28) Basaran O, Cakar N, Uncu N, et al. : Plasma exchange therapy for severe gastrointestinal involvement of Henoch Schonlein purpura in children. Clin Exp Rheumatol 2015 ; 33 : S176-180.
 
29) Villarreal IR, Ortega O, Vigil A, et al. : Henoch-Schonlein nephritis. Adverse effect of treatment with intravenous immunoglobulin. Nephrol Dial Transplant 1999 ; 14 : 795-797.
PubMed
30) Blanco R, Gonzalez-Gay MA, Ibanez D, et al. : Paradoxical and persistent renal impairment in Henoch-Schonlein purpura after high-dose immunoglobulin therapy. Nephron 1997 ; 76 : 247-248.
 
31) Hernstadt HM, Bartlett M, Kausman JY, et al. : Complicated Henoch-Schonlein purpura. J Paediatr Child Health 2015 ; 51 : 639-642.
PubMed
32) Fotis L, Tuttle PV 4th, Baszis KW, et al. : Azathioprine therapy for steroid-resistant Henoch-Schonlein purpura : a report of 6 cases. Pediatr Rheumatol Online J 2016 ; 14 : 37.
PubMed
33) Trapani S, Mariotti P, Resti M, et al. : Severe hemorrhagic bullous lesions in Henoch Schonlein purpura : three pediatric cases and review of the literature. Rheumatol Int 2010 ; 30 : 1355-1359.
PubMed
34) Hasbun T, Chaparro X, Kaplan V, et al. : Bullous Henoch-Schonlein purpura. Case report. Rev Chil Pediatr 2018 ; 89 : 103-106.
PubMed
35) Di Pietro GM, Castellazzi ML, Mastrangelo A, et al. : Henoch-Schonlein Purpura in children : not only kidney but also lung. Pediatr Rheumatol Online J 2019 ; 17 : 75.
 
36) Yilmaz N, Yuksel S, Becerir T, et al. : Myocarditis and intracardiac thrombus due to Henoch-Schonlein purpura : case report and literature review. Clin Rheumatol 2021 ; 40 : 1635-1644.
PubMed
37) Kobayashi O, Wada H, Okawa K, et al. : Schonlein-Henoch's syndrome in children. Contrib Nephrol 1975 ; 4 : 48-71.
PubMed
38) Pillebout E, Alberti C, Guillevin L, et al. : Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schonlein Purpura. Kidney Int 2010 ; 78 : 495-502.
PubMed
39) Uluca U, Ece A, Sen V, et al. : Management of intestinal bleeding with single-dose cyclophosphamide in Henoch-Schonlein Purpura. Pediatr Int 2015 ; 57 : 498-500.
PubMed
40) Maggio MC, Maringhini S, Ragusa SS, et al. : Acute renal insufficiency and pancreatitis in a child with atypical Henoch-Schonlein purpura : efficacy of a single dose of cyclophosphamide. J Int Med Res 2018 ; 46 : 5285-5290.
 
41) Donnithorne KJ, Atkinson TP, Hinze CH, et al. : Rituximab therapy for severe refractory chronic Henoch-Schonlein Purpura. J Pediatr 2009 ; 155 : 136-139.
PubMed
42) Paller AS, Kelly K, Sethi R : Pulmonary hemorrhage : An often fatal complication of Henoch-Schoenlein Purpura. Pediatr Dermatol 1997 ; 14 : 299-302.
PubMed
43) Latta K, von Schnakenburg C, Ehrich JH : A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 2001 ; 16 : 271-282.
PubMed
44) Rivkees SA, Crawford JD : The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA 1988 ; 259 : 2123-2125.
PubMed
45) Martin S, Cramer CH, Heikenen J, et al. : Gastrointestinal symptoms of Henoch-Schonlein purpura treated with mycophenolate mofetil. J Pediatr Gastroenterol Nutr 2006 ; 43 : 245-247.
 
46) Nikibakhsh AA, Mahmoodzadeh H, Karamyyar M, et al. : Treatment of complicated henoch-schonlein purpura with mycophenolate mofetil : a retrospective case series report. Int J Rheumatol 2010 ; 2010 : 254316.
PubMed
47) Chou T, Louissant VR, Adams A, et al. : Successful Treatment of Henoch-Schonlein Purpura With Recurrent Gastrointestinal Involvement With Mycophenolate Mofetil : A Brief Report. Clin Pediatr (Phila) 2015 ; 54 : 900-903.
PubMed
48) Wang H, Zhang B, Li S, et al. : Clinical outcome in pediatric refractory gastrointestinal Henoch-Schonlein purpura treated with mycophenolate mofetil. Eur J Pediatr 2020 ; 179 : 1361-1366.
 
49) Gicchino MF, Iafusco D, Marrapodi MM, et al. : Gastrointestinal Henoch-Schonlein purpura successfully treated with Mycophenolate Mofetil : Description of 2 case reports. Medicine (Baltimore) 2021 ; 100 : e24093.
PubMed
50) Crayne CB, Eloseily E, Mannion ML, et al. : Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura : 8 cases and a review of the literature. Pediatr Rheumatol Online J 2018 ; 16 : 71.
 
51) Hernandez-Rodriguez J, Carbonell C, Miron-Canelo JA, et al. : Rituximab treatment for IgA vasculitis ; A systematic review. Autoimmun Rev 2020 ; 19 : 102490.
 
52) Iijima K, Sako M, Nozu K, et al. : Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group : Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome : a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2014 ; 384 : 1273-1281.
PubMed
53) Wortmann SB, Fiselier TJ, Van De Kar NC, et al. : Refractory severe intestinal vasculitis due to Henoch-Schonlein purpura : successful treatment with plasmapheresis. Acta Paediatr 2006 ; 95 : 622-623.
PubMed
54) Acar B, Arikan FI, Alioglu B, et al. : Successful treatment of gastrointestinal involvement in Henoch-Schonlein purpura with plasmapheresis. Pediatr Nephrol 2008 ; 23 : 2103.
PubMed
55) Chen CL, Chiou YH, Wu CY, et al. : Cerebral vasculitis in Henoch-Schonlein purpura : a case report with sequential magnetic resonance imaging changes and treated with plasmapheresis alone. Pediatr Nephrol 2000 ; 15 : 276-278.
PubMed
56) Gianviti A, Trompeter RS, Barratt TM, et al. : Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis. Arch Dis Child 1996 ; 75 : 186-190.
PubMed
57) Wen YK, Yang Y, Chang CC : Cerebral vasculitis and intracerebral hemorrhage in Henoch-Schonlein purpura treated with plasmapheresis. Pediatr Nephrol 2005 ; 20 : 223-225.
 
58) Eun SH, Kim SJ, Cho DS, et al. : Cerebral vasculitis in Henoch-Schonlein purpura : MRI and MRA findings, treated with plasmapheresis alone. Pediatr Int 2003 ; 45 : 484-487.
PubMed
59) Donghi D, Schanz U, Sahrbacher U, et al. : Life-threatening or organ-impairing Henoch-Schonlein purpura : plasmapheresis may save lives and limit organ damage. Dermatology 2009 ; 219 : 167-170.
PubMed
P.76 掲載の参考文献
1) Dudley J, Smith G, Llewelyn-Edwards A, et al. : Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein Purpura (HSP). Arch Dis Child 2013 ; 98 : 756-763.
PubMed
2) Ronkainen J, Koskimies O, Ala-Houhala M, et al. : Early prednisone therapy in Henoch-Schonlein purpura : a randomized, double-blind, placebo-controlled trial. J Pediatr 2006 ; 149 : 241-247.
 
3) Huber AM, King J, McLaine P, et al. : A randomized, placebo-controlled trial of prednisone in early Henoch Schonlein Purpura [ISRCTN85109383]. BMC Med 2004 ; 2 : 7.
PubMed
4) Jauhola O, Ronkainen J, Koskimies O, et al. : Outcome of Henoch-Schonlein purpura 8 years after treatment with a placebo or prednisone at disease onset. Pediatr Nephrol 2012 ; 27 : 933-939.
PubMed
P.80 掲載の参考文献
1) Mezzano SA, Ruiz-Ortega M, Egido JS : Angiotensin II and Renal Fibrosis. Hypertension 2001 ; 38 : 635-638.
 
2) Kobori H, Nangaku M, Navar LG, et al. : The intrarenal renin-angiotensin system : from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007 ; 59 : 251-287.
 
3) Nishiyama A : Mechanisms Responsible for Renoprotective Effects of Renin-Angiotensin Inhibitors. YAKUGAKU ZASSHI 2012 ; 132 : 455-459.
PubMed
4) Rovin BH, Adler SG, Barratt J, et al. : KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney International 2021 ; 100 : S1-S276.
PubMed
5) Ozen S, Marks SD, Brogan P, et al. : European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 2019 ; 58 : 1607-1616.
PubMed
6) 成田一衛 (監), 厚生労働科学研究費補助金難治性疾患等政策研究事業 (難治性疾患政策研究事業) 難治性腎障害に関する調査研究班 (編) : エビデンスに基づくIgA腎症診療ガイドライン 2020. 東京医学社, 2020.
 
7) 日本小児腎臓病学会 (編) : 小児IgA腎症診療ガイドライン 2020. 診断と治療社, 2020.
 
8) Ninchoji T, Kaito H, Nozu K, et al. : Treatment strategies for Henoch-Schonlein purpura nephritis by histological and clinical severity. Pediatr Nephrol 2011 ; 26 : 563-569.
PubMed
9) Kurt-Sukur ED, Sekar T, Tullus K : Biopsy-proven Henoch-Schonlein purpura nephritis : a single center experience. Pediatr Nephrol 2021 ; 36 : 1207-1215.
PubMed
10) Tudorache E, Azema C, Hogan J, et al. : Even mild cases of paediatric Henoch-Schonlein purpura nephritis show significant long-term proteinuria. Acta Paediatr 2015 ; 104 : 843-848.
PubMed
11) Coppo R, Peruzzi L, Amore A, et al. : IgACE : A Placebo-Controlled, Randomized Trial of Angiotensin-Converting Enzyme Inhibitors in Children and Young People with IgA Nephropathy and Moderate Proteinuria. Journal of the American Society of Nephrology 2007 ; 18 : 1880-1888.
 
12) Praga M, Gutierrez E, Gonzalez E, et al. : Treatment of IgA nephropathy with ACE inhibitors : a randomized and controlled trial. J Am Soc Nephrol 2003 ; 14 : 1578-1583.
 
13) Woo KT, Lau YK, Zhao Y, et al. : Disease progression, response to ACEI/ATRA therapy and influence of ACE gene in IgA nephritis. Cell Mol Immunol 2007 ; 4 : 227-232.
PubMed
14) Kanno Y, Okada H, Yamaji Y, et al. : Angiotensin-converting-enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation. Qjm 2005 ; 98 : 199-203.
PubMed
15) Nakanishi K, Iijima K, Ishikura K, et al. : Efficacy and safety of lisinopril for mild childhood IgA nephropathy : a pilot study. Pediatric Nephrology 2009 ; 24 : 845-849.
PubMed
16) Sekine T, Miura K, Takahashi K, et al. : Children's toxicology from bench to bed--Drug-induced renal injury (1) : The toxic effects of ARB/ACEI on fetal kidney development. J Toxicol Sci 2009 ; 34 Suppl 2 : Sp245-250.
 
17) Branch RL, Martin U : Adverse effects of angiotensin-converting enzyme inhibitors and Angiotensin-II receptor blockers in pregnancy. Adverse Drug Reaction Bulletin 2007 ; 246 : 943-946.
 
P.87 掲載の参考文献
1) Tarshish P, Bernstein J, Edelmann CM Jr. : Henoch-Schonlein purpura nephritis : course of disease and efficacy of cyclophosphamide. Pediatr Nephrol 2004 ; 19 : 51-56.
 
2) Jauhola O, Ronkainen J, Autio-Harmainen H, et al. : Cyclosporine A vs. methylprednisolone for Henoch-Schonlein nephritis : a randomized trial. Pediatr Nephrol 2011 ; 26 : 2159-2166.
PubMed
3) Zhang H, Li X, Xu H, et al. : Effect and safety evaluation of tacrolimus and Tripterygium glycosides combined therapy in treatment of Henoch-Schonlein purpura nephritis. Int J Urol 2021 ; 28 : 1157-1163.
 
4) Kidney Disease : Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group : KDIGO recommendation Chapter 2. Immunoglobulin A nephropathy (IgAN)/immunoglobulin A vasculitis (IgAV). KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidey Int 2021 ; 100 : S115-127.
 
5) Counahan R, Winterborn MH, White RH, et al. : Prognosis of Henoch-Schonlein purpura nephritis in children. Br Med J 1977 ; 2 : 11-14.
PubMed
6) Xia Y, Mao J, Chen Y, et al. : Clinical outcomes in children with Henoch-Schonlein purpura nephritis grade IIIa or IIIb. Pediatr Nephrol 2011 ; 26 : 1083-1088.
PubMed
7) Tanaka H, Suzuki K, Nakahata T, et al. : Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol 2003 ; 18 : 347-350.
PubMed
8) Pirojsakul K, Tangnararatchakit K, Chalermsanyakorn P, et al. : Clinical outcome of children with Henoch-Schonlein purpura nephritis. J Med Assoc Thai 2012 ; 95 : 878-883.
PubMed
9) Bergstein J, Leiser J, Andreoli SP. : Response of crescentic Henoch-Schonlein purpura nephritis to corticosteroid and azathioprine therapy. Clin Nephrol 1998 ; 49 : 9-14.
PubMed
10) Foster BJ, Bernard C, Drummond KN, et al. : Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisolone and azathioprine : A clinical and histopathologic study. J Pediatr 2000 ; 136 : 370-375.
 
11) Singh S, Devidayal, Kumar L, et al. : Severe Henoch-Schonlein nephritis : resolution with azathioprine and steroids. Rheumatol Int 2002 ; 22 : 133-137.
PubMed
12) Shin JI, Park JM, Shin YH, et al. : Can Azathioprine and steroids alter the progression of severe Henoch-Schonlein nephritis in childrens?. Pediatr Nephrol 2005 ; 20 : 1087-1092.
 
13) Koskela M, Jahnukainen T, Enden K, et al. : Methylprednisolone or cyclosporine a in the treatment of Henoch-Schonlein nephritis : a nationwide study. Pediatr Nephrol 2019 ; 34 : 1447-1456.
PubMed
14) Ronkainen J, Autio-Harmainen H, Nuutinen M : Cyclosporin A for the treatment of severe Henoch-Schonlein glomerulonephritis. Pediatr Nephrol 2003 ; 18 : 1138-1142.
PubMed
15) Shin JI, Park JM, Shin YH, et al. : Henoch-Schonlein purpura nephritis with nephrotic-range proteinuria : histological regression possibly associated with cyclosporin A and steroid treatment. Scand J Rheumatol 2005 ; 34 : 392-395.
 
16) Shin JI, Park JM, Shin YH, et al. : Cyclosporin A therapy for severe Henoch-Schonlein nephritis with nephrotic syndrome. Pediatr Nephrol 2005 ; 20 : 1093-1097.
 
17) Park JM, Won SC, Shin JI, et al. : Cyclosporin A therapy for Henoch-Schonlein nephritis with nephrotic-range proteinuria. Pediatr Nephrol 2011 ; 26 : 411-417.
PubMed
18) Zhang DF, Hao GX, Li CZ, et al. : Off-label use of tacrolimus in children with Henoch-Schonlein purpura nephritis : a pilot study. Arch Dis Child 2018 ; 103 : 772-775.
PubMed
19) Ren P, Han F, Chen L, et al. : The combination of Mycophenolate mofetil with corticosteroids induces remission of Henoch-Schonlein purpura nephritis. Am J Nephrol 2012 ; 36 : 271-277.
PubMed
20) Lu Z, Song J, Mao J, et al. : Evaluation of Mycophenolate Mofetil and Low-dose steroid combined therapy in moderately severe Henoch-Schonlein purpura nephritis. Med Sci Monit 2017 ; 23 : 2333-2339.
 
21) Du Y, Hou L, Zhao C, et al. : Treatment of children with Henoch-Schonlein purpura nephritis with mycophenolate mofetil. Pediatr Nephrol 2012 ; 27 : 765-771.
PubMed
22) Hackl A, Becker JU, Korner LM, et al. : Mycophenolate mofetil following glucocorticoid treatment in Henoch-Schonlein purpura nephritis : the role of early initiation and therapeutic drug monitoring. Pediatr Nephrol 2018 ; 33 : 619-629.
PubMed
23) Iijima K, Ito-Kariya S, Nakamura H, et al. : Multiple combined therapy for severe Henoch-Schonlein purpura nephritis in children. Pediatr Nephrol 1998 ; 12 : 244-248.
PubMed
24) Ninchoji T, Kaito H, Nozu K, et al. : Treatment strategies for Henoch-Schonlein purpura nephritis by histological and clinical severity. Pediatr Nephrol 2011 ; 26 : 563-569.
PubMed
25) Nagai S, Horinouchi T, Ninchoji T, et al. : Use of renin-angiotensin system inhibitors as initial therapy in children with Henoch-Schonlein purpura nephritis of moderate severity. Pediatr Nephrol 2022 ; 37 : 1845-1853.
PubMed
26) Goldstein AR, White RH, Akuse R, et al. : Long-term follow-up of childhood Henoch-Schonlein nephritis. Lancet 1992 ; 339 : 280-282.
PubMed
27) Hahn D, Hodson EM, Willis NS, et al. : Interventions for preventing and treating kidney disease in Henoch-Schonlein Purpura (HSP). Cochrane Database Syst Rev 2015 ; 8 : CD005128.
PubMed
28) Ozen S, Marks SD, Brogan P, et al. : European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 2019 ; 58 : 1607-1616.
PubMed
P.90 掲載の参考文献
1) Jauhola O, Ronkainen J, Autio-Harmainen H, et al. : Cyclosporine A vs. methylprednisolone for Henoch-Schonlein nephritis : a randomized trial. Pediatr Nephrol 2011 ; 26 : 2159-2166.
PubMed
2) Koskela M, Jahnukainen T, Enden K, et al. : Methylprednisolone or cyclosporine a in the treatment of Henoch-Schonlein nephritis : a nationwide study. Pediatr Nephrol 2019 ; 34 : 1447-1456.
PubMed
3) Niaudet P, Habib R : Methylprednisolone pulse therapy in the treatment of severe forms of Schonlein-Henoch purpura nephritis. Pediatr Nephrol 1998 ; 12 : 238-243.
PubMed
4) Deng F, Lu L, Zhang Q, et al. : Improved outcome of Henoch-Schonlein purpura nephritis by early intensive treatment. Indian J Pediatr 2012 ; 79 : 207-212.
 
5) Komatsu H, Fujimoto S, Maruyama S, et al. : Distinct characteristics and outcomes in elderly-onset IgA vasculitis (Henoch-Schonlein purpura) withnephritis : Nationwide cohort study of data from the Japan Renal Biopsy Registry (J-RBR). PLoS One 2018 ; 13 : e0196955.
PubMed
P.93 掲載の参考文献
1) Kawasaki Y, Suzuki J, Nozawa R, et al. : Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schonlein nephritis. Pediatrics 2003 ; 111 : 785-789.
PubMed
2) 高橋 昌里 : 紫斑病性腎炎に対するパルス-ウロキナーゼ療法 (総説). 小児科診療 1995 ; 58 : 203-210.
 
3) Ushijima Y, Kawasaki Y, Kaneko M, et al. : A case of Henoch-Schoenlein purpura nephritis recurring after 3 years remission. Fukushima J Med Sci 2010 ; 56 : 50-56.
 
4) Ohara S, Kawasaki Y, Miyazaki K, et al. : Efficacy of cyclosporine A for steroid-resistant severe Henoch-Schonlein purpura nephritis. Fukushima J Med Sci 2013 ; 59 : 102-107.
PubMed
5) Zaffanello M, Brugnara M, Franchini M, et al. : Adjuvant treatments for Henoch-Schonlein purpura nephritis in children : A systematic review. Curr Ther Res Clin Exp 2009 ; 70 : 254-265.
PubMed
P.95 掲載の参考文献
1) Gianviti A, Trompeter RS, Barratt TM, et al. : Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis. Arch Dis Child 1996 ; 75 : 186-190.
PubMed
2) Scharer K, Krmar R, Querfeld U, et al. : Clinical outcome of Schonlein-Henoch purpura nephritis in children. Pediatr Nephrol 1999 ; 1 : 816-823.
PubMed
3) Kawasaki Y, Suzuki J, Murai M, et al. : Plasmapheresis therapy for rapidly progressive Henoch-Schonlein nephritis. Pediatr Nephrol 2004 ; 19 : 920-923.
 
4) Wright E, Dillon MJ, Tullus K : Childhood vasculitis and plasma exchange. Eur J Pediatr 2007 ; 166 : 145-151.
PubMed
5) Hattori M, Ito K, Konomoto T, et al. : Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schonlein purpura nephritis in children. Am J Kidney Dis 1999 ; 33 : 427-433.
PubMed
6) Shenoy M, Ognjanovic MV, Coulthard MG : Treating severe Henoch-Schonlein and IgA nephritis with plasmapheresis alone. Pediatr Nephrol 2007 ; 22 : 1167-1171.
PubMed
7) Jardim HM, Leake J, Risdon RA, et al. : Crescentic glomerulonephritis in children. Pediatr Nephrol 1992 ; 6 : 231-235.
PubMed
8) Pillebout E, Thervet E, Hill G, et al. : Henoch-Schonlein Purpura in adults : outcome and prognostic factors. J Am Soc Nephrol 2002 ; 13 : 1271-1278.
PubMed
9) Augusto JF, Sayegh J, Delapierre L, et al. : Addition of plasma exchange to glucocorticosteroids for the treatment of severe Henoch-Schonlein purpura in adults : a case series. Am J Kidney Dis 2012 ; 59 : 663-669.
PubMed
10) Nossent J, Raymond W, Keen H, et al. : Pregnancy outcomes in women with a history of immunoglobulin A vasculitis. Rheumatology (Oxford) 2019 ; 58 : 884-888.
PubMed
a) Padmanabhan A, Connelly-Smith L, Aqui N, et al. : Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis : The Eighth Special Issue. J Clin Apher 2019 ; 34 : 171-354.
 
P.98 掲載の参考文献
1) Inoue CN, Chiba Y, Morimoto T, et al. : Tonsillectomy in the treatment of pediatric Henoch-Schonlein nephritis. Clin Nephrol 2007 ; 7 : 298-305.
PubMed
2) Kanai H, Sawanobori E, Kobayashi A, et al. : Early treatment with methylprednisolone pulse therapy combined with tonsillectomy for heavy proteinuric henoch-schonlein purpura nephritis in children. Nephron Extra 2011 ; 1 : 101-111.
PubMed
3) Umeda C, Fujinaga S, Endo A, et al. : Preventive Effect of Tonsillectomy on Recurrence of Henoch-Schonlein Purpura Nephritis after Intravenous Methylprednisolone Pulse Therapy. Tohoku J Exp Med 2020 ; 250 : 61-69.
PubMed

書評

最近チェックした商品履歴

Loading...